Our anti-HIV jab will be rolled out in six weeks. But funding cuts hollowed out the system needed to deliver it

South Africa’s uptake of the once-every-six-month HIV prevention jab, lenacapavir (LEN), will be heavily affected by the Trump administration’s funding cuts to the country because it destroyed much of the infrastructure — such as community-based testing and field recruitment for HIV prevention services — needed to create demand for the medicine. 

That’s one of the findings of a report released on Tuesday by the US-based organisation, Physicians for Human Rights and two local non-profits...